| Original language | English |
|---|---|
| Pages (from-to) | 330-331 |
| Number of pages | 2 |
| Journal | Bipolar Disorders |
| Volume | 24 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 05-2022 |
All Science Journal Classification (ASJC) codes
- Psychiatry and Mental health
- Biological Psychiatry
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Bipolar Disorders, Vol. 24, No. 3, 05.2022, p. 330-331.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Observations on the results of a systematic review and network meta-analysis of double-blind randomized, placebo-controlled trials to examine early onset of response to pharmacological intervention for bipolar depression
AU - Kishi, Taro
AU - Ikuta, Toshikazu
AU - Sakuma, Kenji
AU - Okuya, Makoto
AU - Hayakawa, Hiromi
AU - Iwata, Nakao
N1 - Funding Information: The authors have declared that there are no conflicts of interest relating to the subject of this study. Interests from the past three years are as follows. Dr. Kishi received speaker's honoraria from Sumitomo Dainippon, Otsuka, Eisai, Daiichi Sankyo, Janssen, Takeda, Kyowa, Kissei, Meiji, Pfizer, Mochida, Eli Lilly, MSD, Janssen, and Tanabe‐Mitsubishi (Yoshitomi); as well as research grants from Eisai, the Japanese Ministry of Health, Labour and Welfare, Grant‐in‐Aid for Scientific Research (C), and Fujita Health University School of Medicine. Dr. Ikuta has no conflicts of interest with any company. Dr. Sakuma has received speaker's honoraria from Eisai, Kissei, Meiji, Otsuka, and Torii and has received a Fujita Health University School of Medicine Research Grant for Early‐Career Scientists, as well as a Grant‐in‐Aid for Young Scientists (B). Dr. Okuya has received speaker's honoraria from Meiji and has received a Fujita Health University School of Medicine Research Grant for Early‐Career Scientists, as well as a Grant‐in‐Aid for Young Scientists. Ms. Hayakawa has no conflicts of interest with any company. Prof. Iwata received speaker's honoraria from Sumitomo Dainippon, Eli Lilly, Janssen, Meiji, Otsuka, Takeda, and Pfizer as well as research grants from Dainippon Sumitomo, Eisai, Otsuka, and Takeda; along with research grants from Daiichi Sankyo, Takeda, Dainippon Sumitomo Eisai, Meiji Tanabe‐Mitsubishi, and Otsuka.
PY - 2022/5
Y1 - 2022/5
UR - https://www.scopus.com/pages/publications/85120007473
UR - https://www.scopus.com/pages/publications/85120007473#tab=citedBy
U2 - 10.1111/bdi.13164
DO - 10.1111/bdi.13164
M3 - Letter
C2 - 34826195
AN - SCOPUS:85120007473
SN - 1398-5647
VL - 24
SP - 330
EP - 331
JO - Bipolar Disorders
JF - Bipolar Disorders
IS - 3
ER -